Literature DB >> 31793712

Protective impacts of circular RNA VMA21 on lipopolysaccharide-engendered WI-38 cells injury via mediating microRNA-142-3p.

Peili Yang1, Ran Gao1, Wenwen Zhou2, Anbang Han1.   

Abstract

CircRNA derived from vacuolar ATPase assembly factor (circVMA21) is a newly-researched circRNA, which is reported to adjust the degeneration of intervertebral disc. But, function of circVMA21 in infantile pneumonia is yet to be explored. The research surveyed the role of circVMA21 in lipopolysaccharide (LPS)-caused WI-38 cell inflammatory injury. LPS (10 μg/ml, 12 hr) was exploited to arouse WI-38 cell inflammatory injury. Subsequently, the mediatory impacts of microRNA (miR)-142-3p and circVMA21 in LPS-evoked cell injury were detected after transfection with the inhibited or overexpressed vectors. In above processes, cell behaviors of cell viability, apoptosis, and pro-inflammatory factors were monitored. NF-κB and JNK pathways were elucidated to showcase the feasible molecular mechanisms. Results displayed that LPS engendered WI-38 cell inflammatory injury was alleviated as well as activated NF-κB and JNK pathways was interdicted by miR-142-3p suppression. Importantly, restrained miR-142-3p expression was discovered in WI-38 cells after overexpressing circVMA21. Moreover, overexpressed circVMA21 exerted the similar functions as miR-142-3p suppression in LPS-triggered WI-38 cell injury. But, the influence was clearly reversed by miR-142-3p overexpression. Hindered NF-κB and JNK pathways caused by overexpressed circVMA21 was also crippled by miR-142-3p overexpression. The research discolsed that circVMA21 protected WI-38 cells to resist LPS-triggered inflammatory injury via miR-142-3p-NF-κB/JNK axis.
© 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  JNK pathway; NF-κB pathway; hsa_circ_0091702; infantile pneumonia; inflammatory injury

Mesh:

Substances:

Year:  2019        PMID: 31793712     DOI: 10.1002/biof.1593

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.438


  7 in total

1.  Hsa_circ_0018818 knockdown suppresses tumorigenesis in non-small cell lung cancer by sponging miR-767-3p.

Authors:  Xiaohui Xu; Xiaoyun Zhou; Chao Gao; Yushang Cui
Journal:  Aging (Albany NY)       Date:  2020-05-01       Impact factor: 5.682

2.  Circular RNA VMA21 ameliorates sepsis-associated acute kidney injury by regulating miR-9-3p/SMG1/inflammation axis and oxidative stress.

Authors:  Yan Shi; Chuan-Fu Sun; Wen-Han Ge; Ye-Ping Du; Nan-Bin Hu
Journal:  J Cell Mol Med       Date:  2020-08-22       Impact factor: 5.310

Review 3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration.

Authors:  Shaojun Hu; Hongyuan Xing; Jiangnan Zhang; Zemin Zhu; Ying Yin; Ning Zhang; Yiying Qi
Journal:  Stem Cells Int       Date:  2022-02-18       Impact factor: 5.443

4.  Circular RNA VMA21 ameliorates lung injury in septic rat via targeting microRNA-497-5p/CD2-associated protein axis.

Authors:  JinFang Ke; MengFei Chen; ShiLan Ma; Liang Zhang; Ling Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  Circ_0026579 alleviates LPS-induced WI-38 cells inflammation injury in infantile pneumonia.

Authors:  Yang Yu; Tingting Yang; Zhaozheng Ding; Yuan Cao
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

Review 6.  Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs.

Authors:  Lívia Fratini; Mariane Jaeger; Caroline Brunetto de Farias; André T Brunetto; Algemir L Brunetto; Lisa Shaw; Rafael Roesler
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

7.  Circ_0038467 regulates lipopolysaccharide-induced inflammatory injury in human bronchial epithelial cells through sponging miR-338-3p.

Authors:  Guangming Liu; Qiufeng Wan; Jingwen Li; Xinying Hu; Xingli Gu; Sicheng Xu
Journal:  Thorac Cancer       Date:  2020-03-17       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.